Syllabus
Syllabus HEMONK 2022/2023
Teaching week
Teaching form
Topic 1
Lecture
Introduction to red cell disorders I 1
Lecture
Introduction to red cell disorders II 1
Lecture
Introduction to white cell disorders I 2
Lecture
Introduction to white cell disorders II – Acute leukemias 2
Lecture
Disorders of haemostasis 3
Lecture
Hodgkin’s lymphoma, NHL 3
Seminars
Anaemia 4
Lecture
Myeloproliferative disorders (MPD) 4
Lecture
Chronic lymfocytic leukaemia 4
Lecture
Monoclonal gammoptahy and MM (multiple myeloma) 4
Seminars
Diagnostic methods in haematology 5
Lecture
Haematopoietic stem cell transplantation (HSCT), emergency situations in haematology 5
Seminars
Emergency situations in haematology 6
Practical teaching
Immunochemotherapy in haematooncology, supportive care, case studies 8
Seminars
Splenomegaly, lymphadenopathy, diagnostics in malignant lymphoproliferative diseases 9
Seminars
Acute leukaemias, HSCT 10
Seminars
Monoclonal gammoptahy and MM 11
Seminars
Myeloproliferative disorders (MPD), MDS 13
Seminars
Transfusion medicine 14
Practical teaching
Burning topics discussion
Credit test
Annotation
In the subject Haematology and Oncology students will be introduced to the epidemiology, pathogenesis, diagnostics, staging and therapy of both solid tumours and hematological malignancies as well as non-malignant hematological disorders. Theoretical introduction in form of lectures, that provides an overview of crucial topics in the subject, are followed by seminars that provide more detailed insight into respective diseases, their taxonomy, special pathology, diagnostics, clinical course and treatment. During the seminars on non-malignant hematology students learn basics of hematology laboratory practice, both morphology and coagulation part, with laboratory results inerpretation and basics of rational haemotherapy (transfusiology). At the practical lectures students are examining patients with specific malignant diseases. Haematooncological part of practical lectures are focused on case studies with differential diagnosis and treatment. The access to patients with haematological malignancies is limited because of deep immunosupression in most of them, but whenever it is possible, patients with clear signs of haematological disease, especially with lymphadenopathy and splenomegaly, are demonstrated to the students. In the oncological and haematooncological part of the course students learn basics of oncology therapy according to the evidence based medicine, including tageted therapy and modern supportive and palliative care.
Preventive care and early diagnosis principles of both malignant and non- malignant haematologic diseases will be also mentioned.